339. OPAT Outcomes in Patients with Immunocompromise

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) allows patients to complete intravenous (IV) or high risk oral medications outside the acute inpatient setting. Data regarding OPAT in patients with immunocompromise (PWIC) are sparse. PWIC represent a vulnerable population due to underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoney, Monica V, Swords, Kyleen, Le Mahajan, Audrey, Alonso, Carolyn D, Larnard, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679249/
http://dx.doi.org/10.1093/ofid/ofad500.410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679249/
http://dx.doi.org/10.1093/ofid/ofad500.410

Ejemplares similares